<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04512612</url>
  </required_header>
  <id_info>
    <org_study_id>PCC2019/2831</org_study_id>
    <nct_id>NCT04512612</nct_id>
  </id_info>
  <brief_title>Can Pan-Colonic Chromoendoscopy (PCC) Improve Adenoma Detection Rate in FIT-Positive-Patients: A Randomized Study</brief_title>
  <acronym>PCC</acronym>
  <official_title>Can Pan-Colonic Chromoendoscopy (PCC) Improve Adenoma Detection Rate in FIT-Positive-Patients: A Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Singapore General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Singapore General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Colonoscopy is the technique of choice for evaluation of patients with positive fecal occult&#xD;
      blood (FIT). Identification of polyps and their removal has been shown to decrease colorectal&#xD;
      cancer incidence rates and mortality. Many endoscopic imaging technologies and devices have&#xD;
      been developed to increase adenoma detection (ADR) during screening colonoscopies. They vary&#xD;
      in the way they work, and some of the technologies are costly and not widely available.&#xD;
      Studies has shown the simple to use pan-colonic chromoendoscopy can improve ADR compared to&#xD;
      standard colonoscopy. However, there is little evidence on the utility of pan-colonic&#xD;
      chromoendoscopy in asymptomatic individuals undergoing colonoscopy after a positive FIT test.&#xD;
      In this randomized study, the investigators aim to compare the utility of chromoendoscopy and&#xD;
      high-definition white-light endoscopy in asymptomatic individuals undergoing colonoscopy&#xD;
      after a positive FIT test&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eligible subjects with positive screening FIT test referred to the Department of&#xD;
      Gastroenterology, Singapore General Hospital will be approached and recruited. The included&#xD;
      patients will be randomised to either a) Group A- Chromoendoscopy or b) Group B- high&#xD;
      definition white light based evaluation.&#xD;
&#xD;
      Hypothesis:&#xD;
&#xD;
      The investigators hypothesize that application of non-absorbable dye during colonoscopy would&#xD;
      enhance the mucosal contrast, delineate the border and surface patterns by accumulating in&#xD;
      the innominate grooves and, thereby, enhance the detection of adenoma during colonoscopy&#xD;
&#xD;
      Procedure:&#xD;
&#xD;
      Pan-colonic chromoendoscopy and high-definition white light endoscopy will be performed by&#xD;
      five experienced endoscopist, and hospital sedation guidelines will be followed. The&#xD;
      colonoscopy will be performed using Olympus (CF-HQ190) or Fujifilm (EC-590) colonoscopies.&#xD;
      Indigo carmine dye will be used for pan-colonic chromoendoscopy. Two ampules of Indigo&#xD;
      carmine (0.8%, 5ml/ampule) will be dissolved in 250 ml of water and sprayed through the&#xD;
      waterjet channel by using the auxiliary foot pump upon reaching the caecum.&#xD;
&#xD;
      The colonoscopy insertion will be performed using high-definition white light, and the scope&#xD;
      will be advanced till the caecum. The quality of the bowel preparation will be rated&#xD;
      according to the validated Boston bowel preparation score. Participants with inadequate bowel&#xD;
      preparation score (Score &lt;6) will be excluded from the study. The fecal residue will be&#xD;
      washed, suctioned and cleared during insertion to improve visibility. No special care will be&#xD;
      taken to look for lesions during the insertion. Assessment for colonic lesions will only be&#xD;
      performed during withdrawal of the endoscope. The minimum withdrawal time was set at 7&#xD;
      minutes. Randomization: Once the caecum is intubated and if the bowel preparation is&#xD;
      adequate, the participants will be randomized to pan-colonic chromoendoscopy based withdrawal&#xD;
      or high-definition while light based withdrawal. In the pan-colonic chromoendoscopy group,&#xD;
      the indigo carmine was sprayed by pressing the auxiliary foot pump, and dye was delivered&#xD;
      systematically to coat the entire colonic mucosa. In both, the groups, the lesion size,&#xD;
      number, location, morphology will be documented during withdrawal. The investigators&#xD;
      characterized the morphology of the lesion according to the established Paris classification.&#xD;
      The investigators characterized the lesion as flat neoplasm if the lesion project &lt;2.5mm or&#xD;
      polypoid lesion if lesion project &gt;2.5mm into the lumen. The investigators measured the size&#xD;
      of the lesions using an open biopsy forceps when needed.&#xD;
&#xD;
      In both the groups, the identified polyps will be removed using the standard techniques, and&#xD;
      the tissue will be placed in separate formalin bottles and sent for histology assessment. The&#xD;
      histology of the polyps was assessed by dedicated pathologist trained in gastrointestinal&#xD;
      pathology. Both the endoscopists and the pathologist will not be blinded to the study&#xD;
      technique. The investigators defined advanced adenoma as any adenoma &gt;10 mm in size or with&#xD;
      &gt;25% villous histology or high-grade dysplasia. The investigators classified hyperplastic&#xD;
      polyps and sessile serrated polyps (SSA) as serrated lesions, The investigators excluded&#xD;
      hyperplastic lesions in the rectum from the analysis as such lesions are frequently&#xD;
      encountered in the rectum&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 1, 2020</start_date>
  <completion_date type="Anticipated">August 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The participants will be randomised to one of the two groups. The first group will undergo colonoscopy evaluation using pan-colonic chromoendoscopy during withdrawal of endoscope. In the second group, colonoscopy evaluation will be performed using high-definition white light endoscopy during withdrawal</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To evaluate the adenoma detection rate between pan-colonic chromoendoscopy and white light colonoscopy</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Advanced adenoma detection rate white light colonoscopy</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Flat lesion detection rate</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serrated adenoma detection rate</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Withdrawal time comparison</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">250</enrollment>
  <condition>Colon Adenoma</condition>
  <arm_group>
    <arm_group_label>Dye based Chromoendoscopy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients enrolled in this group will undergo pan-colonic chromoendoscopy evaluation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High Definition White Light Endoscopy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients enrolled in this group will undergo high definition white light endoscopy based evaluation</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Chromoendoscopy</intervention_name>
    <description>Participants randomised to Group A will undergo colonoscopic evaluation using dye-based chromoendoscopy</description>
    <arm_group_label>Dye based Chromoendoscopy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>High definition white light colonoscopy</intervention_name>
    <description>Participants randomised to Group B will undergo colonoscopic evaluation using high definition white light endoscopy</description>
    <arm_group_label>High Definition White Light Endoscopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age older than 50 years&#xD;
&#xD;
          -  Positive stool FIT test or FOBT test&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Known inflammatory bowel disease&#xD;
&#xD;
          -  Known polyposis syndromes&#xD;
&#xD;
          -  Previous history of colon cancer and surgical resection&#xD;
&#xD;
          -  Overt gastrointestinal bleeding&#xD;
&#xD;
          -  Stool FIT or FOBT test performed during hospitalization&#xD;
&#xD;
          -  Inadequate bowel preparation (Boston Bowel Preparation score &lt;6 or &lt;2 for each colonic&#xD;
             segment)&#xD;
&#xD;
          -  Poor patient tolerance to the procedure&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Concurrent intake of anticoagulants and thienopyridines (e.g., Clopidogrel), where&#xD;
             these drugs cannot be suspended for the adequate duration before colonoscopy&#xD;
&#xD;
          -  Patient with known history of hypersensitivity to Indigo carmine dye&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Singapore General Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>169608</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <results_reference>
    <citation>Pohl J, Schneider A, Vogell H, Mayer G, Kaiser G, Ell C. Pancolonic chromoendoscopy with indigo carmine versus standard colonoscopy for detection of neoplastic lesions: a randomised two-centre trial. Gut. 2011 Apr;60(4):485-90. doi: 10.1136/gut.2010.229534. Epub 2010 Dec 15.</citation>
    <PMID>21159889</PMID>
  </results_reference>
  <results_reference>
    <citation>Cubiella J, Castells A, Andreu M, Bujanda L, Carballo F, Jover R, Lanas √Å, Morillas JD, Salas D, Quintero E; COLONPREV study investigators. Correlation between adenoma detection rate in colonoscopy- and fecal immunochemical testing-based colorectal cancer screening programs. United European Gastroenterol J. 2017 Mar;5(2):255-260. doi: 10.1177/2050640616660662. Epub 2016 Jul 20.</citation>
    <PMID>28344793</PMID>
  </results_reference>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 10, 2020</study_first_submitted>
  <study_first_submitted_qc>August 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 13, 2020</study_first_posted>
  <last_update_submitted>August 12, 2020</last_update_submitted>
  <last_update_submitted_qc>August 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>FIT- positive</keyword>
  <keyword>Chromoendoscopy</keyword>
  <keyword>white light endoscopy</keyword>
  <keyword>adenoma detection rate</keyword>
  <keyword>advanced adenoma rate</keyword>
  <keyword>serrated adenoma rate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

